Celltrion Files Tocilizumab In US

Korean Biosimilars Giant Submits CT-P47 Actemra Rival To US FDA

Tocilizumab injection syringe
Celltrion has filed its tocilizumab biosimilar in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products